Clinical, Cosmetic and Investigational Dermatology (Oct 2022)
Diagnosis and Management of Cutaneous Manifestations of Autoimmune Connective Tissue Diseases
Abstract
Nathaniel Goldman,1,2 Joseph Han,3 Avery LaChance1 1Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; 2New York Medical College, School of Medicine, Valhalla, NY, USA; 3Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence: Avery LaChance, Connective Tissue Diseases Clinic, Health Policy and Advocacy, Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, 221 Longwood Avenue, Boston, MA, 02215, USA, Tel +1 617-582-6060, Fax +1 617-532-6060, Email [email protected]: The cutaneous features of autoimmune connective tissue disease pose a unique challenge to patients and clinicians managing these conditions. In this review, we outline the key elements of diagnosis and treatment of cutaneous lupus erythematosus, dermatomyositis, systemic sclerosis, and morphea. This article also aims to present an update on gold standard as well as new and emerging therapies for these conditions. Overall, dermatologists can play a key role in diagnosing and treating autoimmune connective tissue diseases and this review intends to provide an up-to-date toolkit to guide clinical dermatologists in this endeavor.Keywords: cutaneous lupus erythematosus, dermatomyositis, systemic sclerosis, morphea, eosinophilic fasciitis
